Diabetes, Obesidad y Reproducción Humana

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Escobar-Morreale HF.

    Surgical management of metabolic dysfunction in PCOS

    Steroids . 77(4, SI): 312-316. Nº de citas: 14

    [doi:10.1016/j.steroids.2011.12.004]

  • Albanell J, González A, Ruiz-Borrego M, Alba E, García-Saenz JA, Corominas JM, Burgues O, Furio V, Rojo A, Palacios J, Bermejo B, Martínez-García M, Limon ML, Muñoz AS, Martín M, Tusquets I, Rojo F, Colomer R, Faull I, Lluch A.

    Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER plus ) node-negative breast cancer

    ANNALS OF ONCOLOGY . 23(3): 625-631. Nº de citas: 93

    [doi:10.1093/annonc/mdr278]

  • Escobar-Morreale HF, Carmina E, Dewailly D, Gambineri A, Kelestimur F, Moghetti P, Pugeat M, Qiao J, Wijeyaratne CN, Witchel SF, Norman RJ.

    Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society

    HUMAN REPRODUCTION UPDATE . 18(2): 146-170. Nº de citas: 243

    [doi:10.1093/humupd/dmr042]

  • Savio AS, Acosta OR, Pérez HG, Alvarez YR, Chico A, Pérez HG, Ojeda MO, Aguero CA, Estévez M, Nieto GG.

    Enhancement of the inhibitory effect of an IL-15 antagonist peptide by alanine scanning

    JOURNAL OF PEPTIDE SCIENCE . 18(1): 25-29. Nº de citas: 9

    [doi:10.1002/psc.1411]

  • Insenser M, Escobar-Morreale HF.

    Application of proteomics to the study of polycystic ovary syndrome

    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION . 34(11): 869-875. Nº de citas: 7

    [doi:10.3275/8108]

  • Álvarez-Blasco F, Luque-Ramírez M, Escobar-Morreale HF.

    Diet composition and physical activity in overweight and obese premenopausal women with or without polycystic ovary syndrome

    GYNECOLOGICAL ENDOCRINOLOGY . 27(12): 978-981. Nº de citas: 24

    [doi:10.3109/09513590.2011.579658]

  • Araña Rosaínz Mde J, Ojeda MO, Acosta JR, Elías-Calles LC, González NO, Herrera OT, García Álvarez CT, Rodríguez EM, Báez ME, Seijas EÁ, Valdés RF.

    Imbalanced Low-Grade Inflammation and Endothelial Activation in Patients with Type 2 Diabetes Mellitus and Erectile Dysfunction

    JOURNAL OF SEXUAL MEDICINE . 8(7): 2017-2030. Nº de citas: 51

    [doi:10.1111/j.1743-6109.2011.02277.x]

  • Escobar-Morreale HF, Luque-Ramírez M.

    Role of androgen-mediated enhancement of erythropoiesis in the increased body iron stores of patients with polycystic ovary syndrome

    FERTILITY AND STERILITY . 95(5): 1730-255. Nº de citas: 12

    [doi:10.1016/j.fertnstert.2011.01.038]

  • Ojeda Ojeda M, Larrondo Muguercia H, Magdariaga Figuerola A, Sánchez Valdivia A, Rodríguez Alonso I, Valenzuela Silva C, García Iglesias E, Domínguez Alonso E, Buurman WA, Araña Rosaínz Mde J.

    Temporal trends of circulating nitric oxide and pro-inflammatory cytokine responses ex vivo in intra-abdominal sepsis: results from a cohort study

    INFLAMMATION RESEARCH . 60(3): 289-297. Nº de citas: 5

    [doi:10.1007/s00011-010-0267-4]

  • Luque-Ramírez M, Álvarez-Blasco F, Alpañés M, Escobar-Morreale HF.

    Role of Decreased Circulating Hepcidin Concentrations in the Iron Excess of Women with the Polycystic Ovary Syndrome

    The Journal of clinical endocrinology and metabolism . 96(3): 846-852. Nº de citas: 31

    [doi:10.1210/jc.2010-2211]

  • Escobar-Morreale HF, Luque-Ramírez M, González F.

    Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis

    FERTILITY AND STERILITY . 95(3): 1048-249. Nº de citas: 263

    [doi:10.1016/j.fertnstert.2010.11.036]

  • Alvarez-Blasco F, Luque-Ramírez M, Escobar-Morreale HF.

    Obesity impairs general health-related quality of life (HR-QoL) in premenopausal women to a greater extent than polycystic ovary syndrome (PCOS)

    CLINICAL ENDOCRINOLOGY . 73(5): 595-601. Nº de citas: 15

    [doi:10.1111/j.1365-2265.2010.03842.x]

  • Luque-Ramírez M, Alpañés M, Escobar-Morreale HF.

    The determinants of insulin sensitivity, beta-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome than in women who do not have hyperandrogenism

    FERTILITY AND STERILITY . 94(6): 2214-2221. Nº de citas: 29

    [doi:10.1016/j.fertnstert.2009.11.049]

  • Balsa JA, Iglesias B, Peromingo R, Conde S, Vazquez C, San-Millan JL, Botella-Carretero JI.

    Vitamin D Receptor Polymorphisms in Secondary Hyperparathyroidism After Scopinaro's Biliopancreatic Diversion

    OBESITY SURGERY . 20(10): 1415-1421. Nº de citas: 8

    [doi:10.1007/s11695-010-0144-9]

  • Luque-Ramírez M, Escobar-Morreale HF.

    Treatment of Polycystic Ovary Syndrome (PCOS) with Metformin Ameliorates Insulin Resistance in Parallel with the Decrease of Serum Interleukin-6 Concentrations

    HORMONE AND METABOLIC RESEARCH . 42(11): 815-820. Nº de citas: 37

    [doi:10.1055/s-0030-1262855]

  • Insenser M, Martínez-García M, Nieto RM, San-Millán JL, Escobar-Morreale HF.

    Impact of the storage temperature on human plasma proteomic analysis: Implications for the use of human plasma collections in research

    PROTEOMICS CLINICAL APPLICATIONS . 4(8-9): 739-744. Nº de citas: 17

    [doi:10.1002/prca.201000007]

  • Insenser M, Martínez-García MA, Montes R, San-Millán JL, Escobar-Morreale HF.

    Proteomic Analysis of Plasma in the Polycystic Ovary Syndrome Identifies Novel Markers Involved in Iron Metabolism, Acute-Phase Response, and Inflammation

    The Journal of clinical endocrinology and metabolism . 95(8): 3863-3870. Nº de citas: 41

    [doi:10.1210/jc.2010-0220]

  • Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, Lobo R, Norman RJ, Talbott E, Dumesic DA.

    Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

    The Journal of clinical endocrinology and metabolism . 95(5): 2038-2049. Nº de citas: 649

    [doi:10.1210/jc.2009-2724]